Lipoprotein(a) is an important factor to determine coronary artery plaque morphology in patients with acute myocardial infarction

BackgroundLipoprotein(a) [Lp(a)] can influence the development and disruption of atherosclerotic plaques through its effect on lipid accumulation. The purpose of this study was to evaluate the relationship between serum Lp(a) levels and plaque morphology of an infarct-related lesion and non-infarct-related lesion of the coronary artery in acute myocardial infarction (AMI). Methods and resultsCoronary plaque morphology was evaluated in 68 patients (age 62.1±12.1 years, mean±SD; men n=58, women n=10) with AMI by intravascular ultrasound with radiofrequency data analysis before coronary intervention and by 64-slice computed tomography angiography within 2 weeks. Patients were divided into a group with an Lp(a) level of 25 mg/dl or more (n=20) and a group with an Lp(a) level of less than 25 mg/dl (n=48). Intravascular ultrasound with radiofrequency data analysis identified four types of plaque components at the infarct-related lesion: fibrous, fibrofatty, dense calcium, and necrotic core. The necrotic core component was significantly larger in the group with an Lp(a) level of 25 mg/dl or more than in the group with an Lp(a) level of less than 25 mg/dl (27.6±8.0 vs. 15.7±10.0%, P=0.0001). Coronary plaques were classified as calcified plaques, noncalcified plaques, mixed plaques, and low-attenuation plaques on 64-slice computed tomography angiography. Computed tomography indicated that the group with an Lp(a) level of 25 mg/dl or more had a greater number of total plaques, noncalcified plaques, and low-attenuation plaques in whole coronary arteries than did the group with an Lp(a) level of less than 25 mg/dl (5.3±1.8 vs. 3.7±2.2, P=0.0061; 4.0±2.0 vs. 1.2±1.3, P=0.0001; 2.2±2.1 vs. 0.5±0.7, P=0.0001, respectively). ConclusionElevated serum Lp(a) levels are associated with the number of plaques and plaque morphology. Patients with a high Lp(a) level during AMI require more intensive treatment for plaque stabilization.

[1]  S. Tsimikas,et al.  Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies. , 2012, Journal of the American College of Cardiology.

[2]  M. Koschinsky,et al.  Mechanisms of lipoprotein(a) pathogenicity: prothrombotic, proatherosclerotic, or both? , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[3]  G. Stone,et al.  Plaque composition by intravascular ultrasound and distal embolization after percutaneous coronary intervention. , 2012, JACC. Cardiovascular imaging.

[4]  T. Kuwahara,et al.  Differential Characteristics of Inflammatory Responses to Stent Implantation Between De Novo and Intrastent Restenosis Lesion in Patients With Stable Angina , 2012, Angiology.

[5]  K. Ejiri,et al.  Usefulness of Lipoprotein (a) for predicting progression of non-culprit coronary lesions after acute myocardial infarction. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[6]  T. Kuwahara,et al.  Coronary artery spatial distribution, morphology, and composition of nonculprit coronary plaques by 64-slice computed tomographic angiography in patients with acute myocardial infarction. , 2010, The American journal of cardiology.

[7]  K. Berg.  A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. , 2009, Acta pathologica et microbiologica Scandinavica.

[8]  Stephen Kaptoge,et al.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. , 2009, JAMA.

[9]  Børge G Nordestgaard,et al.  Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. , 2009, JAMA.

[10]  M. Koschinsky,et al.  Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[11]  B. Nordestgaard,et al.  Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. , 2008, Circulation.

[12]  A. Takahashi,et al.  Quantitative Measures of Coronary Stenosis Severity by 64-Slice CT Angiography and Relation to Physiologic Significance of Perfusion in Nonobese Patients: Comparison with Stress Myocardial Perfusion Imaging , 2008, Journal of Nuclear Medicine.

[13]  S. Oshima,et al.  Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial infarction. , 2007, Journal of the American College of Cardiology.

[14]  D. Vince,et al.  Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[15]  R. Virmani,et al.  Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. , 2006, Journal of the American College of Cardiology.

[16]  Yasuyuki Suzuki,et al.  Diagnostic accuracy of 64-slice computed tomography for detecting angiographically significant coronary artery stenosis in an unselected consecutive patient population: comparison with conventional invasive angiography. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[17]  Arjun Deb,et al.  Lipoprotein(a): New insights into mechanisms of atherogenesis and thrombosis , 2004, Clinical cardiology.

[18]  M. Boffa,et al.  Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models. , 2004, Clinical biochemistry.

[19]  Konstantin Nikolaou,et al.  Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. , 2004, Journal of the American College of Cardiology.

[20]  C. Claussen,et al.  Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with angiographically proven coronary artery disease. , 2004, Journal of the American College of Cardiology.

[21]  S. Achenbach,et al.  Detection of Calcified and Noncalcified Coronary Atherosclerotic Plaque by Contrast-Enhanced, Submillimeter Multidetector Spiral Computed Tomography: A Segment-Based Comparison With Intravascular Ultrasound , 2003, Circulation.

[22]  E. Tuzcu,et al.  Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis , 2002, Circulation.

[23]  B. Nordestgaard,et al.  In vivo transfer of lipoprotein(a) into human atherosclerotic carotid arterial intima. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[24]  B. Nordestgaard,et al.  Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta. , 1996, The Journal of clinical investigation.

[25]  B. Nordestgaard,et al.  Specific accumulation of lipoprotein(a) in balloon-injured rabbit aorta in vivo. , 1996, Circulation research.

[26]  B. G. Brown,et al.  Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). , 1995, JAMA.

[27]  B. Nordestgaard,et al.  Transfer of lipoprotein(a) and LDL into aortic intima in normal and in cholesterol-fed rabbits. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[28]  C. Hamm,et al.  Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a) , 1995, Circulation.

[29]  G. Hoefler,et al.  Lipoprotein Lp(a): A Risk Factor for Myocardial Infarction , 1988, Arteriosclerosis.

[30]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[31]  Markus F Neurath,et al.  Virtual histology. , 2008, Best practice & research. Clinical gastroenterology.

[32]  D. Betteridge,et al.  Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. , 1994, The Journal of clinical investigation.